We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Indian Firm to Acquire 75 Percent of U.S. Generics Company
Indian Firm to Acquire 75 Percent of U.S. Generics Company
April 6, 2005
Indian drugmaker, Jubilant Organosys, plans to acquire 75 percent of an unnamed U.S. generic drug company, Jubilant announced this week.